Literature DB >> 22147571

The in vitro micronucleus assay.

Ann T Doherty1.   

Abstract

The in vitro micronucleus test detects genotoxic damage in interphase cells. The in vitro micronucleus test provides an alterative to the chromosome aberration test, and because the in vitro micronucleus test examines cells at interphase, the assessment of micronuclei can be scored faster, as the analysis of damage is thought to be less subjective and is more amenable to automation.Micronuclei may be the result of aneugenic (whole chromosome) or clastogenic (chromosome breakage) damage. This chapter provides methods for mononucleate and binucleate micronucleus tests and the addition of centromeric labelling and a non-disjunction assay to investigate any potential aneugenic mode of action.

Mesh:

Substances:

Year:  2012        PMID: 22147571     DOI: 10.1007/978-1-61779-421-6_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  A systematic assessment of genotoxicity on pivaloylacylation-7ADCA-a wide existing antibiotic impurity.

Authors:  Qingying Luo; Yang Li; Zunzhen Zhang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  A high-throughput in vivo micronucleus assay for genome instability screening in mice.

Authors:  Gabriel Balmus; Natasha A Karp; Bee Ling Ng; Stephen P Jackson; David J Adams; Rebecca E McIntyre
Journal:  Nat Protoc       Date:  2014-12-31       Impact factor: 13.491

3.  In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi).

Authors:  Annabelle Friedrich; Ann-Sophie Assmann; Lena Schumacher; Jana V Stuijvenberg; Matthias U Kassack; Wolfgang A Schulz; Wynand P Roos; Finn K Hansen; Marc Pflieger; Thomas Kurz; Gerhard Fritz
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

4.  In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation.

Authors:  Emilie Racine; Patrice Nordmann; Lucile Pantel; Matthieu Sarciaux; Marine Serri; Jessica Houard; Philippe Villain-Guillot; Anthony Demords; Carina Vingsbo Lundberg; Maxime Gualtieri
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.